Rosiglitazone (PPARgamma-agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes-atherosclerosis mouse model (Q44287903)
Jump to navigation
Jump to search
scientific article published in January 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosiglitazone (PPARgamma-agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes-atherosclerosis mouse model |
scientific article published in January 2003 |
Statements
1 reference
Rosiglitazone (PPARgamma-agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes-atherosclerosis mouse model (English)
1 reference
1 reference
Shaish A
1 reference
Yacov N
1 reference
Levkovitz H
1 reference
Trestman S
1 reference
Gerber Y
1 reference
Cohen H
1 reference
Dvir A
1 reference
Rhachmani R
1 reference
Ravid M
1 reference
Harats D
1 reference
1 January 2003
1 reference
1 reference
5
1 reference
1
1 reference
45-50
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference